NO20006041D0 - N-Benzodioxanylmethyl-1-piperidylmethylamine compounds with affinity for 5-HT receptors - Google Patents

N-Benzodioxanylmethyl-1-piperidylmethylamine compounds with affinity for 5-HT receptors

Info

Publication number
NO20006041D0
NO20006041D0 NO20006041A NO20006041A NO20006041D0 NO 20006041 D0 NO20006041 D0 NO 20006041D0 NO 20006041 A NO20006041 A NO 20006041A NO 20006041 A NO20006041 A NO 20006041A NO 20006041 D0 NO20006041 D0 NO 20006041D0
Authority
NO
Norway
Prior art keywords
piperidylmethylamine
benzodioxanylmethyl
receptors
affinity
compounds
Prior art date
Application number
NO20006041A
Other languages
Norwegian (no)
Other versions
NO20006041L (en
Inventor
Neil Wishart
Alan Martin Birch
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO20006041D0 publication Critical patent/NO20006041D0/en
Publication of NO20006041L publication Critical patent/NO20006041L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NO20006041A 1998-06-03 2000-11-29 N-Benzodioxanylmethyl-1-piperidylmethylamine compounds with affinity for 5-HT receptors NO20006041L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9811879.7A GB9811879D0 (en) 1998-06-03 1998-06-03 Therapeutic agents
PCT/EP1999/003648 WO1999062902A1 (en) 1998-06-03 1999-05-26 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors

Publications (2)

Publication Number Publication Date
NO20006041D0 true NO20006041D0 (en) 2000-11-29
NO20006041L NO20006041L (en) 2000-11-29

Family

ID=10833098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006041A NO20006041L (en) 1998-06-03 2000-11-29 N-Benzodioxanylmethyl-1-piperidylmethylamine compounds with affinity for 5-HT receptors

Country Status (20)

Country Link
EP (1) EP1087964A1 (en)
JP (1) JP2002517392A (en)
KR (1) KR20010052526A (en)
CN (1) CN1304408A (en)
AR (1) AR018622A1 (en)
AU (1) AU4369599A (en)
BG (1) BG104988A (en)
BR (1) BR9910927A (en)
CA (1) CA2333756A1 (en)
CO (1) CO5021190A1 (en)
GB (1) GB9811879D0 (en)
HR (1) HRP20010005A2 (en)
HU (1) HUP0102233A2 (en)
ID (1) ID27067A (en)
IL (1) IL139552A0 (en)
NO (1) NO20006041L (en)
PL (1) PL344594A1 (en)
SK (1) SK17602000A3 (en)
TR (1) TR200003569T2 (en)
WO (1) WO1999062902A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915616D0 (en) * 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
GB0007376D0 (en) * 2000-03-28 2000-05-17 Knoll Ag Therapeutic agents
AU6392701A (en) * 2000-05-12 2001-11-20 Solvay Pharm Bv Piperazine and piperidine compounds
US20030186838A1 (en) * 2000-05-12 2003-10-02 Feenstra Roelof W. Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
RU2372344C2 (en) * 2004-05-05 2009-11-10 Ф. Хоффманн-Ля Рош Аг Arylsulphonyl benzodioxanes used for modulating 5-ht6 receptor, 5-ht2a receptor or both
JP2008530229A (en) 2005-02-17 2008-08-07 ワイス Cycloalkyl fused indole, benzothiophene, benzofuran and indene derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681325B1 (en) * 1991-09-16 1993-12-17 Fabre Medicament Pierre DERIVATIVES OF AMINOMETHYL-4 PIPERIDINE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
FR2701479B1 (en) * 1993-02-11 1995-05-12 Pf Medicament New heterocyclic derivatives of 4-aminomethyl piperidine, their preparation and their therapeutic use.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
GB9514380D0 (en) * 1995-07-13 1995-09-13 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
EP1087964A1 (en) 2001-04-04
IL139552A0 (en) 2002-02-10
CA2333756A1 (en) 1999-12-09
PL344594A1 (en) 2001-11-05
BR9910927A (en) 2001-02-20
HUP0102233A2 (en) 2002-05-29
WO1999062902A1 (en) 1999-12-09
CN1304408A (en) 2001-07-18
JP2002517392A (en) 2002-06-18
SK17602000A3 (en) 2001-08-06
CO5021190A1 (en) 2001-03-27
AU4369599A (en) 1999-12-20
ID27067A (en) 2001-02-22
AR018622A1 (en) 2001-11-28
BG104988A (en) 2001-11-30
NO20006041L (en) 2000-11-29
GB9811879D0 (en) 1998-07-29
TR200003569T2 (en) 2001-04-20
KR20010052526A (en) 2001-06-25
HRP20010005A2 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
DE69903953D1 (en) 2-SUBSTITUTED-1-PIPERIDYL-BENZIMIDAZOLE COMPOUNDS AS ORL1 RECEPTOR AGONISTS
NO20004912L (en) Compounds with effect on muscarinic receptors
NO20013444L (en) Triazole compounds with the dopamine D3 receptor affinity
ATE331707T1 (en) 4 PIPERAZINYLINDOL DERIVATIVES WITH AFFINITY FOR THE 5-HT6 RECEPTOR
NO20010467L (en) High affinity ligands for nociceptin receptor ORL-1
ATE280157T1 (en) 4-AROYL-PIPERIDINE-CCR-3 RECEPTOR ANTAGONISTS III
FI4209U1 (en) New compounds
ID22562A (en) COMPOSITION FOR DANGEROUS ARTROPODA
NO993089D0 (en) Deepwater lÕringsinnretning
DK0708105T3 (en) 5-HT 4 receptor agonists
IS5641A (en) Azabicyclic 5HT1 receptors bind
NO994106D0 (en) Oxazolidines as 5-HT 2A antagonists
NO976157L (en) Condensed thiazole derivatives with 5-HT receptor affinity
PL344594A1 (en) N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
NO993172D0 (en) Sulfonamide compounds with 5-HT receptor activity
NO972017L (en) Substituted tetracyclic azepine derivatives having affinity for 5-HT 2 receptors
DK1068198T3 (en) 5-Heteroaryl substituted indoles
DE10083631T1 (en) lubricant composition
UA28135C2 (en) MEANS FOR MICROBIOCENOSE CORRECTION
SE0003354D0 (en) Materials with affinity for flavines or related compounds
SI1077935T1 (en) Phenylsulfonamide-phenylethylamines useful as dopamine receptors
IDP000021799A (en) SUBSTITUTED PIROLUM COMPOUNDS
IDP000021790A (en) SUBSTITUTED PIROLUM COMPOUNDS
SE9802981D0 (en) New tetracyclic compounds
IT246012Y1 (en) CUSHIONED SADDLE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application